Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis - Publication - Authors - KSSG Research Database

Publication

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Journal Paper/Review - Jan 4, 2012

Jörger Markus, Matter-Walstra K, Früh Martin, Kühnel U, Szucs T, Pestalozzi B, Schwenkglenks M

Jörger, Markus

chief of service
Medizinische Onkologie und Hämatologie · Dept. I

Matter-Walstra, K

Früh, Martin

Medizinische Onkologie und Hämatologie · Dept. I

Kühnel, U

Szucs, T

Pestalozzi, B

Schwenkglenks, M